Imidazole → HCID 10760398, 화합물

HRID 2299017노트

반응식

HRID 2299017 반응식
[F:1][C:2]1[CH:3]=[C:4]([N+:15]([O-:17])=[O:16])[CH:5]=[CH:6][C:7]=1[N:8]1[CH:12]=[C:11]([CH2:13][OH:14])[N:10]=[CH:9]1.N1C=CN=C1.[Si:23](Cl)([C:26]([CH3:29])([CH3:28])[CH3:27])([CH3:25])[CH3:24]>>[F:1][C:2]1[CH:3]=[C:4]([N+:15]([O-:17])=[O:16])[CH:5]=[CH:6][C:7]=1[N:8]1[CH:12]=[C:11]([CH2:13][O:14][Si:23]([C:26]([CH3:29])([CH3:28])[CH3:27])([CH3:25])[CH3:24])[N:10]=[CH:9]1

참가 물질

4

실험 절차

3-Fluoro-4-(4-hydroxymethylimidazol-1-yl)nitrobenzene (26.7 g) and imidazole (15.3 g) were suspended in dry N,N-dimethylformnamide (190 ml) and stirred under argon on an ice-bath. t-Butyldimethylsilylchloride (25.5 g) was added in one portion, and stirring continued at ice temperature for 30 minutes, then at ambient temperature overnight. Solvent was evaporated in vacuo at 30° C., the residue diluted with water (200 ml) and extracted into ethyl acetate (700 ml). After washing with water (2×300 ml), brine, and drying over magnesium sulfate, solvent was evaporated (finally on high vacuum) to give an oil which solidified (39.2 g). This was used in the next stage with no further purification.

후처리

  1. stirringstirring
  2. customat ambient temperature
  3. customovernight
  4. customSolvent was evaporated in vacuo at 30° C.
  5. additionthe residue diluted with water (200 ml)
  6. extractionextracted into ethyl acetate (700 ml)
  7. washAfter washing with water (2×300 ml), brine
  8. dry with materialdrying over magnesium sulfate, solvent
  9. customwas evaporated (finally on high vacuum)
  10. customto give an oil which
  11. customThis was used in the next stage with no further purification

출처 및 근거

ORD 기록
ord-58f2879112654cf7a11b0c5b5e466555
출처 데이터셋
uspto-grants-2002_12
특허 번호
US06495551B1

반응 노트

불러오는 중…